Abstract
Synthesis of 1,11-dithia-4,8-diazacyclotetradecane (L1), a constitutional isomer of the macrocyclic [14]aneN2S2 series, is accompanied with reaction and method optimization. Chelation of L1 with copper(II) provided assessment of lattice packing, ring contortion, and evidence of conformational fluxionality in solution through two unique crystal structures: L1Cu(ClO4)2 and [(L1Cu)2μ-Cl](ClO4)3. Multiple synthetic approaches are presented, supplemented with reaction methodology and reagent screening to access [14]aneN2S2 L1. Reductive alkylation of bis-tosyl-cystamine was integrated into the synthetic route, eliminating the use and isolation of volatile thiols and streamlining the synthetic scale-up. Late-stage cleavage of protecting sulfonamides was addressed using reductive N-S cleavage to furnish macrocyclic freebase L1.
Original language | English |
---|---|
Pages (from-to) | 11091-11102 |
Number of pages | 12 |
Journal | Journal of Organic Chemistry |
Volume | 84 |
Issue number | 17 |
DOIs | |
State | Published - Sep 6 2019 |
Externally published | Yes |
Funding
The authors thank the Ohio Board of Regents for funds used to purchase the Bruker-Nonius Apex CCDC X-ray diffractometer and the National Science Foundation (CHE-0840446). The authors thank the University of Notre Dame Mass Spectrometry and Proteomics Facility, supported by NSF grant CHE-0741793, for exact mass measurements on compound 2 and Indiana University Bloomington Mass Spectrometry Facility for exact mass measurements on all additional compounds. This work was also supported by NIH 1R15 GM119074-01.
Funders | Funder number |
---|---|
Indiana University Bloomington Mass Spectrometry Facility | |
University of Notre Dame Mass Spectrometry and Proteomics Facility | |
National Science Foundation | CHE-0741793, CHE-0840446 |
National Institutes of Health | |
National Institute of General Medical Sciences | R15GM119074 |
Ohio Board of Regents |